A wireless continuous glucose monitoring solution designed and developed in the Kingdom of Saudi Arabia — Zaghwan’s first step into human-health biotech.
MARiN is Zaghwan’s flagship biotech initiative, developed under Al Sahli Holding.
The system combines a small wireless sensor with a companion mobile app to support people managing their carbohydrate metabolism with real-time data, trend visualisation, and configurable alerts — all delivered through a discreet, easy-to-use design.
MARiN is being developed end-to-end in Saudi Arabia, supporting Vision 2030 objectives for healthcare localisation and advanced medical-device manufacturing.
MARiN is currently in the development and prototyping phase.
The product is not yet available for commercial sale.
Regulatory submissions to the Saudi FDA and other applicable bodies are planned as part of the next phase of validation.
For partnership, investor, or clinical-collaboration inquiries, please contact us.